Brief: Todd Deutsch Says Significant Change In AIM ImmunoTech's Board Is Urgently Needed - SEC Filing
15/07/2024 22:27
July 15 (Reuters) - AIM ImmunoTech Inc AIM.A :
* TODD DEUTSCH SAYS SIGNIFICANT CHANGE IN AIM IMMUNOTECH'S
BOARD
IS URGENTLY NEEDED - SEC FILING
* TODD DEUTSCH SAYS EXCPECT AIM IMMUNOTECH BOARD TO PROMPTLY
AMEND
BYLAWS IN WAY THAT IS CONSISTENT WITH FIDUCIARY DUTIES
* TODD DEUTSCHA: REITERATES IT IS NOT THEIR INTENTION TO
ACQUIRE
CONTROL STAKE IN AIM IMMUNOTECH'S SHARES OF COMMON STOCK
Source text for Eikon: ID:n0001193125-24-179109
Further company coverage: AIM.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AIM ImmunoTech
See all newsBrief: Aim Immunotech Duripanc Primary Endpoint Analysis To Begin December 2026 Topline Results Expected Q1 2027
Brief: Aim Immunotech Files To Offer And Resell Up To 13.08 Million Shares Of Common Stock By Selling Stockholders
Brief: AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market Under NYSE American Rules
Brief: Aim Immunotech Announces Significant Increase In Stockholder Equity And Extension Of Promissory Note Maturity Date To June 2027
Brief: Aim Immunotech Announces 50% Objective Response Rate (Orr) In Upmc Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential